Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study
Author:
Gatell José M1, Assoumou Lambert2, Moyle Graeme3, Waters Laura4, Johnson Margaret5, Domingo Pere6, Fox Julie7, Martinez Esteban1, Stellbrink Hans-Jürgen8, Guaraldi Giovanni9ORCID, Masia Mar10, Gompels Mark11, De Wit Stephane12, Florence Eric13, Esser Stefan14, Raffi François15, Stephan Christoph16, Rockstroh Juergen17, Giacomelli Andrea18, Vera Jaime19, Bernardino José Ignacio20, Winston Alan21, Saumoy Maria22, Gras Julien23, Katlama Christine24, Pozniak Anton L3, Vandekerckhove Linos, Caluwé Els, De Wit Stephane, Necsoi Coca, Florence Eric, Van Frankenhuijsen Maartje, Raffi Francois, Allavena Clotilde, Reliquet Véronique, Cavellec Morane, Rodallec Audrey, Le Tourneau Thierry, Connault Jérôme, Molina Jean-Michel, Ferret Samuel, Previlon Miresta, Yazdanpanah Yazdan, Landman Roland, Joly Véronique, Martinez Adriana Pinto, Katlama Christine, Caby Fabienne, Ktorza Nadine, Schneider Luminita, Stephan Christoph, Wolf Timo, Schüttfort Gundolf, Rockstroh Juergen, Wasmuth Jan-Christian, Schwarze-Zander Carolynne, Boesecke Christoph, Stellbrink Hans-Jurgen, Hoffmann Christian, Sabranski Michael, Esser Stephan, Jablonka Robert, Wiehler Heidi, Behrens Georg, Stoll Matthias, Ahrenstorf Gerrit, Guaraldi Giovanni, Nardini Giulia, Beghetto Barbara, Montforte Antonella D’Arminio, Bini Teresa, Cogliandro Viola, Di Pietro Massimo, Fusco Francesco Maria, Galli Massimo, Rusconi Stefano, Giacomelli Andrea, Meraviglia Paola, Martinez Esteban, González-Cordón Ana, Torres Berta, Domingo Pere, Mateo Gracia, Gutierrez Mar, Portillo Joaquin, Merino Esperanza, Reus Sergio, Boix Vicente, Masia Mar, Gutiérrez Félix, Padilla Sergio, Clotet Bonaventura, Negredo Eugenia, Bonjoch Anna, Casado José L, Bañón-Escandell Sara, Saban Jose, Duque Africa, Podzamczer Daniel, Saumoy Maria, Acerete Laura, Gonzalez-Garcia Juan, Bernardino José Ignacio, Arribas José Ramón, Hontañón; Victor, Moyle Graeme, Pagani Nicole, Bracchi Margherita, Vera Jaime, Clarke Amanda, Adams Tanya, Richardson Celia, Winston Alan, Mora-Peris Borja, Mullaney Scott, Waters Laura, de Esteban Nahum, Milinkovic Ana, Pett Sarah, Fox Julie, Tiraboschi Juan Manuel, Johnson Margaret, Youle Mike, Orkin Chloe, Rackstraw Simon, Hand James, Gompels Mark, Jennings Louise, Nicholls Jane, Johnston Sarah,
Affiliation:
1. Hospital Clinic/Institut d’Investigacions Biomediques August Pi i Suñer, University of Barcelona and ViiV Healthcare, Spain 2. Institut national de la santé et de la recherche médicale (INSERM), Sorbonne Université, Institut Pierre Louis d’épidémiologie et de Santé Publique, Unite Medical pour la Recherche Scientifique 1136, Paris, France 3. Chelsea and Westminster Hospital and St Stephens AIDS Trust, London, United Kingdom 4. Mortimer Market Center, London, United Kingdom 5. Royal Free Hospital, London, United Kingdom 6. Hospital de Sant Pau, Barcelona, Spain 7. Guys and St Thomas` Hospital, London, United Kingdom 8. Infektionsmedizinisches Study Centrum, Hamburg, Germany 9. University of Modena and Reggio Emilia, Modena, Italy 10. Hospital de Elche, Spain 11. Southmead Hospital, Bristol, United Kingdom 12. Saint Pierre Hospital, Université Libre de Bruxelles, Brussels 13. Institute of Tropical Medicine, Antwerp, Belgium 14. Universitatsklinikum, Essen, Germany 15. Infectious Diseases University Hospital and Centre d’Investigation Clinique, Unite d’Investigation Clinique 1413 INSERM, Centre Hopitalier Universitaire Nantes, France 16. Klinikum der Goethe Universitat, Frankfurt 17. Medizinische Klinik und Poliklinik, Bonn, Germany 18. Hospital Luigi Sacco, Milan, Italy 19. Global Health and Infection, Brighton and Sussex Medical School, United Kingdom 20. Hospital La Paz, Madrid, Spain 21. St Mary’s Hospital, London, United Kingdom 22. Hospital de Bellvitge, Barcelona, Spain 23. Hopital St Louis 24. Pitie-Salpetriere Hospital, Paris, France
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Reference34 articles.
1. Backbones versus core agents in initial ART regimens: one game, two players;Llibre;J Antimicrob Chemother,2016 2. Dolutegravir - a review of the pharmacology, efficacy, and safety in the treatment of HIV;Kandel;Drug Des Devel Ther,2015 3. Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study;Martínez;AIDS,2010 4. Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials;Eron;Lancet,2010 5. Twenty years of boosting antiretroviral agents: where are we today;Boffito;AIDS,2015
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|